Skip to Main Content

Meeting the Challenge of Coronavirus

Scientists, scholars, and physicians across Yale are actively engaged in research, innovation, and clinical efforts to combat COVID-19 (2019 Novel Coronavirus). This website seeks to facilitate collaboration at Yale and across the world by transparently communicating our research progress and patient care initiatives.

If you are a member of the Yale community, resources and guidance from the university are available on the Yale COVID-19 website.

Yale Study Connects Long COVID with Autoantibodies

The term "long Covid" is used to describe patients whose medical problems continue long after the coronavirus has left their system. Immunologists Akiko Iwasaki, PhD, and Aaron Ring, MD, PhD, have identified autoantibodies in patients who have had COVID-19. Autoantibodies are antibodies (proteins produced in response to a pathogen) that mistakenly target and react with a person's own tissues or organs. The Yale team has identified these autoantibodies in other systems of the body, which may help to explain why some patients develop specific conditions from the virus, including post-COVID syndrome. More research is needed to determine if long Covid patients have these autoantibodies, which may be a potential therapeutic target for COVID-19.

Watch video

Understanding COVID-19: How Vaccines Work with Your Immune System

When a virus enters our bodies, our immune system acts to eliminate it. Vaccines mimic the infection, providing a blueprint that tells the immune system how to respond. Immunologists Akiko Iwasaki, PhD, and Ruslan Medzhitov, PhD, explain how the COVID-19 vaccine works to prevent coronavirus from entering our cells.

Watch video